State Street Corp. Maintains Passive Stake in Arcturus Therapeutics
Ticker: ARCT · Form: SC 13G/A · Filed: Jan 25, 2024 · CIK: 1768224
| Field | Detail |
|---|---|
| Company | Arcturus Therapeutics Holdings Inc. (ARCT) |
| Form Type | SC 13G/A |
| Filed Date | Jan 25, 2024 |
| Risk Level | low |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: institutional-ownership, amended-filing, passive-investment
TL;DR
**State Street still owns Arcturus shares, no big changes here.**
AI Summary
State Street Corporation, a major financial institution, filed an amended SC 13G/A on January 25, 2024, disclosing its ownership of Arcturus Therapeutics Holdings Inc. common stock as of December 31, 2023. This filing indicates that State Street continues to hold a significant, though passive, stake in Arcturus, a pharmaceutical company. For investors, this means a large institutional investor maintains confidence in Arcturus, which can be a positive signal, but it doesn't suggest any active involvement in the company's management or strategy.
Why It Matters
This filing shows that a major institutional investor, State Street Corporation, continues to hold shares in Arcturus Therapeutics, signaling ongoing institutional interest in the company.
Risk Assessment
Risk Level: low — This is a routine update from a passive institutional investor and does not indicate any immediate risks or significant changes to the company's operations or stock.
Analyst Insight
An investor should note that State Street Corporation's continued passive ownership suggests institutional confidence, but this filing alone doesn't provide new catalysts for Arcturus Therapeutics. It's a routine disclosure of an existing position.
Key Players & Entities
- State Street Corporation (company) — the reporting person filing the SC 13G/A
- Arcturus Therapeutics Holdings Inc. (company) — the subject company whose common stock is being reported
- 03969T109 (other) — the CUSIP number for Arcturus Therapeutics Holdings Inc. common stock
- December 31, 2023 (date) — the date of the event which required the filing of this statement
- January 25, 2024 (date) — the filing date of the SC 13G/A
FAQ
What type of filing is this document?
This document is an SC 13G/A, which is an amended Schedule 13G filing under the Securities Exchange Act of 1934.
Who is the reporting person in this filing?
The reporting person is State Street Corporation, with an I.R.S. Identification No. of 04-2456637.
What company's securities are being reported on?
The securities being reported on are the Common Stock of Arcturus Therapeutics Holdings Inc.
What is the CUSIP number for the securities mentioned?
The CUSIP number for the Common Stock of Arcturus Therapeutics Holdings Inc. is 03969T109.
What was the date of the event that triggered this filing?
The date of the event which required the filing of this statement was December 31, 2023.
Filing Details
This Form SC 13G/A (Form SC 13G/A) was filed with the SEC on January 25, 2024 regarding Arcturus Therapeutics Holdings Inc. (ARCT).